298 related articles for article (PubMed ID: 3524576)
1. Digestion of the host erythrocyte by malaria parasites is the primary target for quinoline-containing antimalarials.
Zarchin S; Krugliak M; Ginsburg H
Biochem Pharmacol; 1986 Jul; 35(14):2435-42. PubMed ID: 3524576
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of 4-aminoquinoline-containing antimalarial drugs on hemoglobin digestion in Plasmodium falciparum-infected erythrocytes.
Famin O; Ginsburg H
Biochem Pharmacol; 2002 Feb; 63(3):393-8. PubMed ID: 11853690
[TBL] [Abstract][Full Text] [Related]
3. Quinoline antimalarials: mechanisms of action and resistance.
Foley M; Tilley L
Int J Parasitol; 1997 Feb; 27(2):231-40. PubMed ID: 9088993
[TBL] [Abstract][Full Text] [Related]
4. Effects of quinoline-containing antimalarials on the erythrocyte membrane and their significance to drug action on Plasmodium falciparum.
Ginsburg H; Krugliak M
Biochem Pharmacol; 1988 May; 37(10):2013-8. PubMed ID: 3288209
[TBL] [Abstract][Full Text] [Related]
5. Studies on the antimalarial mode of action of quinoline-containing drugs: time-dependence and irreversibility of drug action, and interactions with compounds that alter the function of the parasite's food vacuole.
Krugliak M; Ginsburg H
Life Sci; 1991; 49(17):1213-9. PubMed ID: 1943436
[TBL] [Abstract][Full Text] [Related]
6. Antimalarials increase vesicle pH in Plasmodium falciparum.
Krogstad DJ; Schlesinger PH; Gluzman IY
J Cell Biol; 1985 Dec; 101(6):2302-9. PubMed ID: 3905824
[TBL] [Abstract][Full Text] [Related]
7. Defining the timing of action of antimalarial drugs against Plasmodium falciparum.
Wilson DW; Langer C; Goodman CD; McFadden GI; Beeson JG
Antimicrob Agents Chemother; 2013 Mar; 57(3):1455-67. PubMed ID: 23318799
[TBL] [Abstract][Full Text] [Related]
8. Alkalinization of the food vacuole of malaria parasites by quinoline drugs and alkylamines is not correlated with their antimalarial activity.
Ginsburg H; Nissani E; Krugliak M
Biochem Pharmacol; 1989 Aug; 38(16):2645-54. PubMed ID: 2669763
[TBL] [Abstract][Full Text] [Related]
9. Antimalarial quinolines and artemisinin inhibit endocytosis in Plasmodium falciparum.
Hoppe HC; van Schalkwyk DA; Wiehart UI; Meredith SA; Egan J; Weber BW
Antimicrob Agents Chemother; 2004 Jul; 48(7):2370-8. PubMed ID: 15215083
[TBL] [Abstract][Full Text] [Related]
10. The fate of ferriprotorphyrin IX in malaria infected erythrocytes in conjunction with the mode of action of antimalarial drugs.
Zhang J; Krugliak M; Ginsburg H
Mol Biochem Parasitol; 1999 Mar; 99(1):129-41. PubMed ID: 10215030
[TBL] [Abstract][Full Text] [Related]
11. Inhibition by anti-malarial drugs of haemoglobin denaturation and iron release in acidified red blood cell lysates--a possible mechanism of their anti-malarial effect?
Gabay T; Krugliak M; Shalmiev G; Ginsburg H
Parasitology; 1994 May; 108 ( Pt 4)():371-81. PubMed ID: 8008450
[TBL] [Abstract][Full Text] [Related]
12. In vitro sensitivity of Plasmodium falciparum isolates from Burma to chloroquine quinine and mefloquine.
Lwin M; Zaw M
Southeast Asian J Trop Med Public Health; 1985 Sep; 16(3):453-8. PubMed ID: 2937157
[TBL] [Abstract][Full Text] [Related]
13. Quinoline-resistance reversing agents for the malaria parasite Plasmodium falciparum.
van Schalkwyk DA; Egan TJ
Drug Resist Updat; 2006; 9(4-5):211-26. PubMed ID: 17064951
[TBL] [Abstract][Full Text] [Related]
14. [In vitro susceptibility of P. falciparum isolates from Abidjan (Côte d'Ivoire) to quinine, artesunate and chloroquine].
Touré AO; Koné LP; Jambou R; Konan TD; Demba S; Beugre GE; Koné M
Sante; 2008; 18(1):43-7. PubMed ID: 18684691
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of efflux of quinolines as new therapeutic strategy in malaria.
Henry M; Alibert S; Rogier C; Barbe J; Pradines B
Curr Top Med Chem; 2008; 8(7):563-78. PubMed ID: 18473883
[TBL] [Abstract][Full Text] [Related]
16. Effects of combinations of quinoline-containing antimalarials on Plasmodium falciparum in culture.
Geary TG; Bonanni LC; Jensen JB; Ginsburg H
Ann Trop Med Parasitol; 1986 Jun; 80(3):285-91. PubMed ID: 3541805
[TBL] [Abstract][Full Text] [Related]
17. Plasmodium falciparum malaria: rosettes are disrupted by quinine, artemisinin, mefloquine, primaquine, pyrimethamine, chloroquine and proguanil.
Goldring JD; Padayachee T; Ismail I
Mem Inst Oswaldo Cruz; 1999; 94(5):667-74. PubMed ID: 10464415
[TBL] [Abstract][Full Text] [Related]
18. The susceptibility of the malarial parasite Plasmodium falciparum to quinoline-containing drugs is correlated to the lipid composition of the infected erythrocyte membranes.
Shalmiev G; Ginsburg H
Biochem Pharmacol; 1993 Aug; 46(3):365-74. PubMed ID: 8347162
[TBL] [Abstract][Full Text] [Related]
19. A 2-amino quinoline, 5-(3-(2-(7-chloroquinolin-2-yl)ethenyl)phenyl)-8-dimethylcarbamyl-4,6-dithiaoctanoic acid, interacts with PfMDR1 and inhibits its drug transport in Plasmodium falciparum.
Edaye S; Reiling SJ; Leimanis ML; Wunderlich J; Rohrbach P; Georges E
Mol Biochem Parasitol; 2014 Jun; 195(1):34-42. PubMed ID: 24914817
[TBL] [Abstract][Full Text] [Related]
20. Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites.
Slater AF; Cerami A
Nature; 1992 Jan; 355(6356):167-9. PubMed ID: 1729651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
